Cargando…
Imatinib administration in two patients with liver metastases from GIST and severe jaundice
Imatinib is the only effective and approved systemic therapy for the treatment of patients with advanced gastrointestinal stromal tumours (GISTs). Although metastases from GISTs most commonly involve the liver, yielding hyperbilirubinaemia, very few data on imatinib administration in subjects with j...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394355/ https://www.ncbi.nlm.nih.gov/pubmed/14562006 http://dx.doi.org/10.1038/sj.bjc.6601282 |